Citation: Rw. Wagner et Wm. Flanagan, ANTISENSE TECHNOLOGY AND PROSPECTS FOR THERAPY OF VIRAL-INFECTIONS AND CANCER, Molecular medicine today, 3(1), 1997, pp. 31-38
Citation: Wm. Flanagan et Rw. Wagner, POTENT AND SELECTIVE GENE INHIBITION USING ANTISENSE OLIGODEOXYNUCLEOTIDES, Molecular and cellular biochemistry, 172(1-2), 1997, pp. 213-225
Authors:
LIU JB
FLANAGAN WM
DRAZBA JA
ESTES ML
BARNETT GH
HAQQI T
KONDO S
BARNA BP
Citation: Jb. Liu et al., THE CDK INHIBITOR, P27(KIP1), IS REQUIRED FOR IL-4 REGULATION OF ASTROCYTE PROLIFERATION, The Journal of immunology, 159(2), 1997, pp. 812-819
Citation: Wm. Flanagan et al., ELUCIDATION OF GENE-FUNCTION USING C-5 PROPYNE ANTISENSE OLIGONUCLEOTIDES, Nature biotechnology, 14(9), 1996, pp. 1139-1145
Citation: Wm. Flanagan et al., EFFECTS OF OLIGONUCLEOTIDE LENGTH, MISMATCHES AND MESSENGER-RNA LEVELS ON C-5 PROPYNE-MODIFIED ANTISENSE POTENCY, Nucleic acids research, 24(15), 1996, pp. 2936-2941
Authors:
LEWIS JG
LIN KY
KOTHAVALE A
FLANAGAN WM
MATTEUCCI MD
DEPRINCE RB
MOOK RA
HENDREN RW
WAGNER RW
Citation: Jg. Lewis et al., A SERUM-RESISTANT CYTOFECTIN FOR CELLULAR DELIVERY OF ANTISENSE OLIGODEOXYNUCLEOTIDES AND PLASMID DNA, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3176-3181
Authors:
NOURSE J
FIRPO E
FLANAGAN WM
COATS S
POLYAK K
LEE MH
MASSAGUE J
CRABTREE GR
ROBERTS JM
Citation: J. Nourse et al., INTERLEUKIN-2-MEDIATED ELIMINATION OF THE P27(KIP1) CYCLIN-DEPENDENT KINASE INHIBITOR PREVENTED BY RAPAMYCIN, Nature, 372(6506), 1994, pp. 570-573